Raisio plc, Stock Exchange Release, Inside information on 6 November 2026 at 9:30 EET
Raisio plc lowers its guidance for net sales and comparable EBIT for 2026. The updated guidance is based on weaker-than-expected sales performance towards the end of 2026. In addition, the guidance is also affected by higher-than-anticipated costs of the company's ongoing ERP project.
Raisio projects that net sales for the 2026 financial year will be at the same level as in 2025 and comparable EBIT will be at the level of 2025 or decrease slightly compared to 2025.
Raisio projects that net sales and comparable EBIT for the financial year 2026 will increase compared to 2025.
Based on preliminary, unaudited information, Raisio plc's net sales for January-September totalled EUR 171.3 (169.0) million and comparable EBIT was EUR 21.5 (22.7) million.
| M€ | 7-9/26 | 7-9/25 | Change | 1-9/26 | 1-9/25 | Change |
| Net sales | 57.8 | 56.7 | 2.1% | 171.3 | 169.0 | 1.3% |
| Comparable EBIT | 8.4 | 8.6 | -2.3% | 21.5 | 22.7 | -5.2% |
Raisio will publish its Interim Report for January-September 2026 on Tuesday, 10 November 2026. Raisio will not comment on the Interim Report for January-September before it is published.
Raisio plc
Board of Directors
Further information:
Elli Siltala, CEO, tel. +358 02 443 2111
Raisio plc
Raisio's beloved brands make life more fulfilling for millions of people across Europe. We make food that combines delicious taste and convenience with scientifically proven health benefits in a way that gets people hooked on good habits. Our strong brands, such as Benecol® and Elovena®, turn our ambitions into reality. We stay hungry for growth and we aim to be distinctly more inventive than others. We have around 350 professionals focused on healthy food in six countries and export to more than 40 markets around the world. Raisio's shares are listed on Nasdaq Helsinki Ltd. In 2025, the Group's comparable net sales for continuing operations were EUR 224.2 million and the comparable EBIT was EUR 28.5 million. www.raisio.com